ID

27383

Descripción

Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00777699

Link

https://clinicaltrials.gov/show/NCT00777699

Palabras clave

  1. 10/11/17 10/11/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

10 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Cancer NCT00777699

Eligibility Cancer NCT00777699

  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00777699
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed diagnosis of:
Descripción

Diagnosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011900
advanced solid tumor that is no longer responding to therapies or
Descripción

Solid tumour Advanced Unresponsive to Treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205269
advanced or metastatic nsclc that has previously been treated with erlotinib or gefitinib
Descripción

Prior Therapy Non-Small Cell Lung Carcinoma Advanced | Prior Therapy Non-small cell lung cancer metastatic | erlotinib | gefitinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0007131
UMLS CUI [1,3]
C0205179
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0278987
UMLS CUI [3]
C1135135
UMLS CUI [4]
C1122962
ecog performance status 0-1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate organ and bone arrow function as defined by hematological and serum chemistry limits
Descripción

Organ function Hematologic | Bone Marrow function Hematologic | Organ function Serum Chemistry Measurement | Bone Marrow function Serum Chemistry Measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205488
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
UMLS CUI [2,3]
C0205488
UMLS CUI [3,1]
C0678852
UMLS CUI [3,2]
C1883010
UMLS CUI [4,1]
C0005953
UMLS CUI [4,2]
C0031843
UMLS CUI [4,3]
C1883010
at least 18 years old
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
both men and women must practice adequate contraception
Descripción

Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
restriction of some therapies/medications within specific timeframes prior to enrollment and during the study including prior therapy with pi3k, cytotoxic chemotherapy, biologic agents, nitrosoureas or mitomycin c, small-molecule kinase inhibitors, non-cytotoxic hormonal agents
Descripción

PI3K | Cytotoxic Chemotherapy | Biological Factors | Nitrosoureas | Mitomycin | Other Coding | Non-Cytotoxic Agent Hormonal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0044602
UMLS CUI [2]
C0677881
UMLS CUI [3]
C0005515
UMLS CUI [4]
C0028210
UMLS CUI [5]
C0002475
UMLS CUI [6]
C3846158
UMLS CUI [7,1]
C2827065
UMLS CUI [7,2]
C0458083
erlotinib intolerant
Descripción

Intolerance to erlotinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1135135
taking oral corticosteroids chronically or > 1 mg/day warfarin
Descripción

Adrenal Cortex Hormones Oral chronic | Warfarin U/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C0043031
UMLS CUI [2,2]
C0456683
not recovered from the toxic effects of prior therapy
Descripción

Toxic effect Due to Prior Therapy | Recovery Lacking

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332268
history of diabetes mellitus and an hgba1c > 7%
Descripción

Diabetes Mellitus | Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0202054
uncontrolled intercurrent illness
Descripción

Comorbidity Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
pregnant or breastfeeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
congestive heart failure, unstable angina, or a myocardial infarction within 3 months of entering the study.
Descripción

Congestive heart failure | Angina, Unstable | Myocardial Infarction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0027051
hiv positive
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
diagnosis of another malignancy may exclude subject from study
Descripción

Cancer Other

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707251

Similar models

Eligibility Cancer NCT00777699

  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00777699
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosis
Item
confirmed diagnosis of:
boolean
C0011900 (UMLS CUI [1])
Solid tumour Advanced Unresponsive to Treatment
Item
advanced solid tumor that is no longer responding to therapies or
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
Prior Therapy Non-Small Cell Lung Carcinoma Advanced | Prior Therapy Non-small cell lung cancer metastatic | erlotinib | gefitinib
Item
advanced or metastatic nsclc that has previously been treated with erlotinib or gefitinib
boolean
C1514463 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C1514463 (UMLS CUI [2,1])
C0278987 (UMLS CUI [2,2])
C1135135 (UMLS CUI [3])
C1122962 (UMLS CUI [4])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Organ function Hematologic | Bone Marrow function Hematologic | Organ function Serum Chemistry Measurement | Bone Marrow function Serum Chemistry Measurement
Item
adequate organ and bone arrow function as defined by hematological and serum chemistry limits
boolean
C0678852 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0205488 (UMLS CUI [2,3])
C0678852 (UMLS CUI [3,1])
C1883010 (UMLS CUI [3,2])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
C1883010 (UMLS CUI [4,3])
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Contraceptive methods
Item
both men and women must practice adequate contraception
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
PI3K | Cytotoxic Chemotherapy | Biological Factors | Nitrosoureas | Mitomycin | Other Coding | Non-Cytotoxic Agent Hormonal
Item
restriction of some therapies/medications within specific timeframes prior to enrollment and during the study including prior therapy with pi3k, cytotoxic chemotherapy, biologic agents, nitrosoureas or mitomycin c, small-molecule kinase inhibitors, non-cytotoxic hormonal agents
boolean
C0044602 (UMLS CUI [1])
C0677881 (UMLS CUI [2])
C0005515 (UMLS CUI [3])
C0028210 (UMLS CUI [4])
C0002475 (UMLS CUI [5])
C3846158 (UMLS CUI [6])
C2827065 (UMLS CUI [7,1])
C0458083 (UMLS CUI [7,2])
Intolerance to erlotinib
Item
erlotinib intolerant
boolean
C1744706 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
Adrenal Cortex Hormones Oral chronic | Warfarin U/day
Item
taking oral corticosteroids chronically or > 1 mg/day warfarin
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0043031 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Toxic effect Due to Prior Therapy | Recovery Lacking
Item
not recovered from the toxic effects of prior therapy
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Diabetes Mellitus | Glucohemoglobin measurement
Item
history of diabetes mellitus and an hgba1c > 7%
boolean
C0011849 (UMLS CUI [1])
C0202054 (UMLS CUI [2])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Congestive heart failure | Angina, Unstable | Myocardial Infarction
Item
congestive heart failure, unstable angina, or a myocardial infarction within 3 months of entering the study.
boolean
C0018802 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
HIV Seropositivity
Item
hiv positive
boolean
C0019699 (UMLS CUI [1])
Cancer Other
Item
diagnosis of another malignancy may exclude subject from study
boolean
C1707251 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial